You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 2, FEBRUARY 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (69)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Methotrexate-Induced Hepatic Injury in an Adult

A Case Report

ROBERT A. O'ROURKE, MD; GERALD E. ECKERT, MD

Arch Intern Med. 1964;113(2):191-194.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1948 methotrexate, a folic acid antagonist, was introduced by Farber and his associates as a chemotherapeutic agent for the treatment of leukemia.1 Since that time many clinical and experimental studies have shown the folic acid antagonist to be of variable benefit in the treatment of a number of neoplasms,2-7 as well as the epidermal hyperplastic disorder, psoriasis.8

The folic acid antagonists have produced undesirable side effects in many cases because of a narrow margin of safety between therapeutic and toxic dosages. Anemia, leukopenia, thrombocytopenia, stomatitis, and gastrointestinal ulcerations have been reported following this mode of therapy.1,2,4,9,10,12

Skin rashes, alopecia, and erythrocytic macrocytosis with a megaloblastic bone marrow have also occurred.1,2,11,12

A rare complication following treatment with folic acid antagonists is periportal fibrosis of the liver. In 1955 Colsky reported the occurrence of hepatic fibrosis in children with acute leukemia, following treatment with methotrexate. . . . [Full Text PDF of this Article]


Author Affiliations

WASHINGTON, DC

From the Department of Medicine, Georgetown University Medical School and the Georgetown University Hospital.


Footnotes

Received for publication June 21, 1963; accepted Sept 6.

Senior Assistant Resident, Department of Medicine, Georgetown University Hospital (Dr. O'-Rourke); former Fellow in Gastroenterology, Georgetown University Hospital (Dr. Eckert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.